Edwards Lifesciences Corp - 8-K Filing
Edwards Lifesciences stockholders approved an increase of 7,000,000 shares in the Long-Term Stock Incentive Compensation Program at their May 7, 2026 annual meeting. The total share limit was raised to 341,500,000. All director nominees were elected with majority support ranging from 98% (David T. Feinberg) to 91% (Paul A. LaViolette). (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security Holders The final results of voting for each matter submitted to a vote of stockholders at the An, 9.01 Financial Statements and Exhibits(d) Exhibits)
Tickers: $EW